Loading clinical trials...
Loading clinical trials...
Phase 3 Companion Study of Intranasal Metoclopramide in Men With Symptomatic Diabetic Gastroparesis
Conditions
Interventions
Metoclopramide Nasal Spray
Placebo Nasal Spray
Locations
49
United States
Birmingham Gasteroenterology Associates, P.C.
Birmingham, Alabama, United States
Digestive Specialists of the Southeast
Dothan, Alabama, United States
Clinical Research Associates
Huntsville, Alabama, United States
Central Arizone Medical Associates/Clinical Research Advantage
Mesa, Arizona, United States
Preferred Research Partners
Little Rock, Arkansas, United States
Arkansas Gastroenterology
Sherwood, Arkansas, United States
Start Date
April 1, 2014
Primary Completion Date
August 1, 2016
Completion Date
October 1, 2016
Last Updated
July 7, 2020
NCT07324785
NCT04254549
NCT04028492
NCT06340828
NCT03544229
NCT04208698
Lead Sponsor
Evoke Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions